Kelly L. Moore

3.3k citations

45 papers · 2.2k indexed · 2 hit papers · h-index 23

Co-authors: Manisha Patel Mark J. van der Laan Janice B. Schwartz Grace M. Lee Kathleen Dooling Edward A. Belongia Rafael Harpaz Angela Guo
Topics: Vaccine Coverage and Hesitancy (11 papers)Virology and Viral Diseases (7 papers)Hepatitis B Virus Studies (6 papers)
Cited by: Health Hepatology Epidemiology
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
Partner nations: United States United Kingdom Switzerland

In The Last Decade

Kelly L. Moore

44 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines

2018 434 citations Kathleen Dooling, Angela Guo et al. MMWR Morbidity and Mortality Weekly Report profile →
Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

2022 110 citations Mark K. Weng, Mona Doshani et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers

Countries citing papers authored by Kelly L. Moore

Since Specialization

Citations

This map shows the geographic impact of Kelly L. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly L. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly L. Moore more than expected).

Fields of papers citing papers by Kelly L. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly L. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly L. Moore. The network helps show where Kelly L. Moore may publish in the future.

Co-authorship network of co-authors of Kelly L. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly L. Moore. A scholar is included among the top collaborators of Kelly L. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly L. Moore. Kelly L. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Universal hepatitis B vaccination in adults aged 19–59 years: Updated recommendations of the advisory committee on immunization practices—United States, 2022 2022 ·American Journal of Transplantation ·Mark K. Weng,Mona Doshani,Mohammed A. Khan,Sharon E. Frey,Kevin A. Ault,Kelly L. Moore,Eric Hall,Rebecca L. Morgan,Doug Campos‐Outcalt,C. William Wester,Noele P. Nelson	10
2	Supporting immunization programs to address COVID-19 vaccine hesitancy: Recommendations for national and community-based stakeholders 2022 ·Vaccine ·(unknown),Kelly L. Moore,Robert A. Bednarczyk	2
3	Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022breakdown → 2022 ·MMWR Morbidity and Mortality Weekly Report ·Mark K. Weng,Mona Doshani,Mohammed A. Khan,Sharon E. Frey,Kevin A. Ault,Kelly L. Moore,Eric Hall,Rebecca L. Morgan,Doug Campos‐Outcalt,C. William Wester,Noele P. Nelson	110
4	The CAPACITI Decision-Support Tool for National Immunization Programs 2021 ·Value in Health ·(unknown),Birgitte Giersing,Martin I. Meltzer,Anna-Léa Kahn,Mark Jit,Nathalie El Omeiri,Joseph Biey,Kelly L. Moore,Praveen Thokala,Jason M. Mwenda,Melanie Bertram,Rob Baltussen,Raymond Hutubessy	15
5	Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers 2020 ·Vaccine ·Ümit Kartoğlu,Kelly L. Moore,John Lloyd	27
6	Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma 2019 ·Clinical Cancer Research ·Steven B. Maron,Leah M. Chase,Samantha Lomnicki,Sara Kochanny,Kelly L. Moore,Smita S. Joshi,(unknown),(unknown),Lesli A. Kiedrowski,Rebecca J. Nagy,Richard B. Lanman,Seung Tae Kim,Jeeyun Lee,Daniel V.T. Catenacci	147
7	CDC Guidance for Use of a Third Dose of MMR Vaccine During Mumps Outbreaks 2019 ·Journal of Public Health Management and Practice ·Mariel Marlow,Mona Marin,Kelly L. Moore,Manisha Patel	21
8	Factors and considerations for establishing and improving seasonal influenza vaccination of health workers: Report from a WHO meeting, January 16–17, Berlin, Germany 2019 ·Vaccine ·Thomas Cherian,(unknown),Carsten Mantel,Philipp Lambach,Salah Al Awaidy,Joseph Bresee,Supamit Chunsuttiwat,Daouda Coulibaly,Luzhao Feng,Rachel Hale,Shabir A. Madhi,Helena C. Maltezou,Kelly L. Moore,Jonathan S. Nguyen‐Van‐Tam,Saad B. Omer,Gregory A. Poland,Sabine Wicker	30
9	Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines 2018 ·American Journal of Transplantation ·Kathleen Dooling,Angela Guo,Manisha Patel,Grace M. Lee,Kelly L. Moore,Edward A. Belongia,Rafael Harpaz	43
10	Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccinesbreakdown → 2018 ·MMWR Morbidity and Mortality Weekly Report ·Kathleen Dooling,Angela Guo,Manisha Patel,Grace M. Lee,Kelly L. Moore,Edward A. Belongia,Rafael Harpaz	434
11	From refrigerator to arm: Issues in vaccination delivery 2014 ·Vaccine ·Litjen Tan,Melissa A. Barnett,(unknown),(unknown),Jesse M. Hackell,(unknown),(unknown),Kelly L. Moore,Susan J. Rehm,Mitchel C. Rothholz,Charlotte Smith,(unknown),(unknown)	12
12	Evaluation of the feasibility of a state-based vaccine safety advice network 2014 ·Vaccine ·S. Williams,Claudia Vellozzi,Kathryn M. Edwards,Kelly L. Moore,(unknown),C. Buddy Creech	1
13	Patterns of chronic co-morbid medical conditions in older residents of U.S. nursing homes: Differences between the sexes and across the agespan 2014 ·The journal of nutrition health & aging ·Kelly L. Moore,W. John Boscardin,Michael A. Steinman,Janice B. Schwartz	82
14	Social, Structural and Behavioral Determinants of Overall Health Status in a Cohort of Homeless and Unstably Housed HIV-Infected Men 2012 ·PLoS ONE ·Elise D. Riley,Torsten B. Neilands,Kelly L. Moore,Jennifer Cohen,David R. Bangsberg,Diane V. Havlir	42
15	Failure of Pharmacogenetic-based Dosing Algorithms to Identify Older Patients Requiring Low Daily Doses of Warfarin 2011 ·Journal of the American Medical Directors Association ·Janice B. Schwartz,L. Kane,Kelly L. Moore,Alan H.B. Wu	16
16	Robust extraction of covariate information to improve estimation efficiency in randomized trials 2011 ·Statistics in Medicine ·Kelly L. Moore,Romain Neugebauer,Thamban Valappil,Mark J. van der Laan	21
17	Ambient Ozone Concentrations Cause Increased Hospitalizations for Asthma in Children: An 18-Year Study in Southern California 2008 ·Environmental Health Perspectives ·Kelly L. Moore,Romain Neugebauer,Fred Lurmann,Jane V. Hall,(unknown),(unknown),Ira B. Tager	67
18	Microbial Risk Assessment Framework for Exposure to Amended Sludge Projects 2008 ·Environmental Health Perspectives ·Joseph N. S. Eisenberg,Kelly L. Moore,(unknown),(unknown),John M. Colford	40
19	Covariate adjustment in randomized trials with binary outcomes: Targeted maximum likelihood estimation 2008 ·Statistics in Medicine ·Kelly L. Moore,Mark J. van der Laan	124
20	Neonatal Sepsis in Egypt Associated With Bacterial Contamination of Glucose-Containing Intravenous Fluids 2005 ·The Pediatric Infectious Disease Journal ·Kelly L. Moore,Marion Kainer,Nadia Badrawi,Salma Afifi,Momtaz O. Wasfy,Moataza Bashir,William R. Jarvis,(unknown),Amani El‐Kholy,Reginald Gipson,Daniel B. Jernigan,Frank Mahoney	44

About Kelly L. Moore

Kelly L. Moore is a scholar working on Health, Geriatrics and Gerontology and Hepatology, having authored 45 papers that have together received 2.2k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (11 papers), Virology and Viral Diseases (7 papers) and Hepatitis B Virus Studies (6 papers). The work is most often cited by research in Health (360 citations), Hepatology (322 citations) and Epidemiology (1.1k citations). Kelly L. Moore has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Manisha Patel, Mark J. van der Laan, Janice B. Schwartz, Grace M. Lee, Kathleen Dooling, Edward A. Belongia, Rafael Harpaz, Angela Guo, W. John Boscardin and Michael A. Steinman. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact